ACTGen is Drug Discovery in Japan that focus on stem cell transplantation business. Founded in 2005. They cover business area such as developer, medicine, drug, research, development, gene therapy, stem cell transplantation, genetic engineering, monoclonal antibody technology, cancer treatment, healthcare institution.
2005
( 19 years old in 2024 )
Stem Cell Transplantation
-
15-502 Akaho
Komagane, 399-4117
Japan
Private
developermedicinedrugresearchdevelopmentgene therapystem cell transplantationgenetic engineeringmonoclonal antibody technologycancer treatmenthealthcare institution
* We use standard office opening hours in near ACTGen's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ACTGen is Drug Discovery business from Japan that founded in 2005 (19 years old in 2024), ACTGen business is focusing on Stem Cell Transplantation.
ACTGen headquarter office and corporate office address is located in 15-502 Akaho Komagane, 399-4117 Japan.
ACTGen was founded in Japan.
In 2024, ACTGen is currently focus on stem cell transplantation sector.
Above is snippet of Google Trends for "stem cell transplantation" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ACTGen, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
